Achievement of glycaemic targets with weight loss and without hypoglycaemia in type 2 diabetes with the once-weekly glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist tirzepatide: a post hoc analysis of the SURPASS-1 to 5 studies
"The human microbiome and estrogen metabolism." Cell Press, Trends in Endocrinology & Metabolism
This dual focus on nutrition and exercise not only promotes weight loss with semaglutide but also fosters a healthier lifestyle overall
With the 'famine' signal gone and the aromatase burden lifted, the HPG axis can come back onlineoften stronger than before
The TMA consisted of 109 primary tumours collected before chemotherapy, 19 primary tumours collected after chemotherapy, and 28 recurrent tumours that were subsequently treated with second-line chemotherapy
Yes, semaglutide at a higher dose (2.4 mg) is FDA-approved for chronic weight management in adults with obesity or overweight who have at least one weight-related condition